Funding & Partnership Opportunities
We’re driving innovation in early detection and prevention of lung cancer through grants, partnerships, and mission investing.
Our approach spans the discovery, development, validation, and translation of concepts and technologies—prioritizing work with a clear path to clinical impact and applicability to a broad population.
Grants
We fund investigator-led research through competitive grants that advance early detection, prevention, and understanding of lung cancer risk.
Funding opportunities will be typically offered through targeted requests for applications. Sign-up below to learn about upcoming opportunities.
Partnerships
We partner with academic institutions, healthcare organizations, non-profits, and industry to accelerate translational lung cancer research.
Our first collaborative initiative is a biorepository providing access to clinically annotated samples enriched for screening-ineligible populations and early-stage disease to support development of early detection technologies.
Mission Investing
We invest in early-stage companies developing innovative early detection technologies through a venture philanthropy model.
In addition to catalytic capital, we provide hands-on scientific, clinical, and operational support to help companies advance and have real-world impact.
Get Updates About Funding Opportunities
Sign up to receive notifications about grants, partnerships, and mission-related investment opportunities.
Current Partnership Opportunity
Early Detection Bioregistry Program
We are creating a shared research resource that assembles de-identified health information and biological samples from consenting participants with different smoking histories and stages of lung cancer. This resource helps support the discovery, development, and validation of early detection biomarkers. We welcome partnerships with academic and industry test developers to validate assays and evaluate new technologies using this shared resource.
